
Please try another search
Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name. In addition, the company offers essences, creams, lotions, eye creams, facial treatment toners, and skin repairing essences under the AGLab name; skincare oils, body lotions, and dry skin gels under the Bio-Oil name; and children skincare products under the Mister Baby brand, as well as operates ISISPHARMA, a dermatology laboratory specialized in the development and distribution of dermo-cosmetic products. Further, it engages in the research and development of Multikine, an immunotherapy drug for head and neck cancer, which is in Phase III clinical study; NC-6004, a platinum-based micelle chemotherapeutic drug that is in Phase III clinical study; ASC-J9, a molecular chemical entity drug that has completed Phase IIb clinical study for androgen receptor degradation; and 2ccPA, a derivative of phospholipid to patients with symptomatic osteoarthritis of the knee, which is in Phase I clinical trail. Orient EuroPharma Co., Ltd. was founded in 1982 and is based in Taipei, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Peter Tsai | - | - | Chairman, CEO & President |
Jack Wu | - | - | Director |
Hwa-Min Lin | - | - | Independent Director |
Peter Wang | - | - | Representative Director |
Cynthia Lin | - | - | Representative Director |
Chih-Chen Chou | - | - | Supervisor |
Harry Tsai | - | - | Supervisor |
Richard Yang | - | - | Independent Supervisor |
Chih-Cheng Chou | - | 2025 | Independent Director |
Mon-Lin Tsai | - | 2025 | Representative Director |
Jinh-Hong Tsai | - | 2025 | Representative Director |
Jia-Cing Peng | - | 2025 | Independent Director |
Ching-Hsin Hsu | - | 2025 | Independent Director |
Shui-Yung Lin | - | 2025 | Independent Director |
Su-Fen Lin | - | 2025 | Representative Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review